128 related articles for article (PubMed ID: 35760938)
41. SARS-COV-2 vaccine responses in renal patient populations.
Smith RM; Cooper DJ; Doffinger R; Stacey H; Al-Mohammad A; Goodfellow I; Baker S; Lear S; Hosmilo M; Pritchard N; Torpey N; Jayne D; Yiu V; Chalisey A; Lee J; Vilnar E; Cheung CK; Jones RB
BMC Nephrol; 2022 May; 23(1):199. PubMed ID: 35641961
[TBL] [Abstract][Full Text] [Related]
42. Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
Jeewandara C; Kamaladasa A; Pushpakumara PD; Jayathilaka D; Aberathna IS; Danasekara DRSR; Guruge D; Ranasinghe T; Dayarathna S; Pathmanathan T; Somathilake G; Deshan Madhusanka PA; Ramu ST; Pramanayagam Jayadas TT; Kuruppu H; Wijesinghe A; Thashmi Nimasha HM; Milroy D; Nandasena AA; Nilanka Sanjeewani PKG; Wijayamuni R; Samaraweera S; Schimanski L; Tan TK; Dong T; Ogg GS; Townsend A; Malavige GN
Nat Commun; 2021 Jul; 12(1):4617. PubMed ID: 34326317
[TBL] [Abstract][Full Text] [Related]
43. Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.
Hollstein MM; Münsterkötter L; Schön MP; Bergmann A; Husar TM; Abratis A; Eidizadeh A; Schaffrinski M; Zachmann K; Schmitz A; Holsapple JS; Stanisz-Bogeski H; Schanz J; Fischer A; Groß U; Leha A; Zautner AE; Schnelle M; Erpenbeck L
Allergy; 2022 Aug; 77(8):2381-2392. PubMed ID: 35124800
[TBL] [Abstract][Full Text] [Related]
44. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
[TBL] [Abstract][Full Text] [Related]
45. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
[TBL] [Abstract][Full Text] [Related]
46. Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
Dag Berild J; Bergstad Larsen V; Myrup Thiesson E; Lehtonen T; Grøsland M; Helgeland J; Wolhlfahrt J; Vinsløv Hansen J; Palmu AA; Hviid A
JAMA Netw Open; 2022 Jun; 5(6):e2217375. PubMed ID: 35699955
[TBL] [Abstract][Full Text] [Related]
47. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia.
Yang SL; Mat Ripen A; Leong CT; Lee JV; Yen CH; Chand AK; Koh K; Abdul Rahim NAB; Gokilavanan V; Mohamed NNEB; Sevalingam RKA; Sulaiman N; Ab Razak AKB; Mohd Nor NHB; Pong MK; Tai KY; Toh V; Woon YL; Peariasamy KM
Emerg Microbes Infect; 2022 Dec; 11(1):1262-1271. PubMed ID: 35412409
[TBL] [Abstract][Full Text] [Related]
49. Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study.
Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A
Diabetes Metab Syndr; 2022 Feb; 16(2):102424. PubMed ID: 35150961
[TBL] [Abstract][Full Text] [Related]
50. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
51. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
Gaur P; Agrawat H; Shukla A
Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
[TBL] [Abstract][Full Text] [Related]
52. A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
Kulkarni PS; Padmapriyadarsini C; Vekemans J; Bavdekar A; Gupta M; Kulkarni P; Garg BS; Gogtay NJ; Tambe M; Lalwani S; Singh K; Munshi R; Meshram S; Selvavinayagam TS; Pandey K; Bhimarasetty DM; Ramakrishnan SR; Bhamare C; Dharmadhikari A; Vadakkedath R; Bonhomme CJ; Thakar M; Kurle SN; Kelly EJ; Gautam M; Gupta N; Panda S; Bhargava B; Shaligram U; Kapse D; Gunale B;
EClinicalMedicine; 2021 Dec; 42():101218. PubMed ID: 34870133
[TBL] [Abstract][Full Text] [Related]
53. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
[TBL] [Abstract][Full Text] [Related]
54. Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine.
Rangsrisaeneepitak V; Porntharukchareon T; Dechates B; Sirisreetreerux S; Tawinprai K
Diabetol Int; 2022 Oct; 13(4):637-643. PubMed ID: 35528950
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V; Martins-Filho OA; Gouvea MDPG; Camacho LAB; Villela DAM; de Lima SMB; Azevedo AS; Neto LFP; Domingues CMAS; de Medeiros Junior NF; Moulaz IR; Dias LH; Miyamoto ST; Teixeira-Carvalho A; Mill JG;
Front Immunol; 2022; 13():966416. PubMed ID: 36105814
[TBL] [Abstract][Full Text] [Related]
56. Human Milk Antibody Response After Combining Two Different COVID-19 Vaccines: Mix-and-Match.
Mulleners SJ; Juncker HG; van Gils MJ; van Goudoever JB; van Keulen BJ
J Hum Lact; 2022 Aug; 38(3):401-406. PubMed ID: 35726498
[TBL] [Abstract][Full Text] [Related]
57. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
[No Abstract] [Full Text] [Related]
58. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Aikawa NE; Kupa LVK; Medeiros-Ribeiro AC; Saad CGS; Yuki EFN; Pasoto SG; Rojo PT; Pereira RMR; Shinjo SK; Sampaio-Barros PD; Andrade DCO; Halpern ASR; Fuller R; Souza FHC; Guedes LKN; Assad APL; Moraes JCB; Lopes MRU; Martins VAO; Betancourt L; Ribeiro CT; Sales LP; Bertoglio IM; Bonoldi VLN; Mello RLP; Balbi GGM; Sartori AMC; Antonangelo L; Silva CA; Bonfa E
Ann Rheum Dis; 2022 Jul; 81(7):1036-1043. PubMed ID: 35277389
[TBL] [Abstract][Full Text] [Related]
59. Autoimmune rheumatic diseases and COVID-19 vaccination: a retrospective cross-sectional study from Astana.
Rutskaya-Moroshan K; Abisheva S; Sarsenova M; Ogay V; Vinnik T; Aubakirova B; Abisheva A
Reumatologia; 2024; 62(1):26-34. PubMed ID: 38558898
[TBL] [Abstract][Full Text] [Related]
60. Aseptic meningitis following AZD1222 COVID-19 vaccination.
Zavari A; Hamidabad NM; Hassanzadeh M
Am J Emerg Med; 2022 May; 55():225.e5-225.e6. PubMed ID: 34955313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
